Travere Therapeutics logo
Travere Therapeutics TVTX
$ 18.4 -0.89%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Travere Therapeutics Cash and Cash Equivalents 2011-2024 | TVTX

Annual Cash and Cash Equivalents Travere Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
58.2 M 61.7 M 166 M 84.8 M 62.4 M 103 M 99.4 M 41 M 37.8 M 18.2 M 6 M 11.4 K 10.1 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
166 M 10.1 K 56.8 M

Quarterly Cash and Cash Equivalents Travere Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
36.4 M 32.3 M 43.3 M 58.2 M 144 M 70.9 M 161 M 61.7 M 151 M 180 M 257 M 166 M 150 M 83.3 M 148 M 84.8 M 84.8 M 84.8 M 84.8 M 62.4 M 62.4 M 62.4 M 62.4 M 103 M 103 M 103 M 103 M 99.4 M 99.4 M 99.4 M 99.4 M 41 M 41 M 41 M 41 M 37.8 M 37.8 M 37.8 M 37.8 M 18.2 M 18.2 M 18.2 M 18.2 M 6 M 6 M 6 M 6 M 11 K 11.4 K 11.4 K 11.4 K 10.1 K 3.89 K 3.93 K -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
257 M 3.89 K 65.8 M